CHP
CASI

Cable Hill Partners’s CASI Pharmaceuticals CASI Stock Holding History

Cable Hill Partners’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7
Closed – – 727
2015
Q1 		$0 Hold
7
– – ﹤0.01% 724
2014
Q4 		$0 Buy
+7
New +$110 ﹤0.01% 705

Other funds holding CASI

WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CNB
City National Bank Beverly Hills, Delaware $11.6B AUM 3.11% 1-Year Est. Return

Cable Hill Partners's CASI Position: Q2 2015 in Review

Cable Hill Partners sold out of CASI Pharmaceuticals (CASI) in Q2 2015, closing a stake of 7 shares.

Cable Hill Partners first reported a position in CASI in Q4 2014 and held it in 2 quarters. The position peaked at $0 in Q1 2015. 29 funds tracked by Wall St. Rank hold CASI as of Q2 2015.

  • Cable Hill Partners reported no remaining CASI Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Cable Hill Partners sold 7 CASI Pharmaceuticals shares in Q2 2015.
  • Cable Hill Partners first reported a position in CASI Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Cable Hill Partners's CASI Pharmaceuticals position peaked at $0 in Q1 2015.
  • 29 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2015.

Based on Cable Hill Partners's 13F filing for Q2 2015, filed 4 Aug 2016.